Plain-English translation of NCT07518004 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new implanted glucose monitoring device called the ROME GS System. Researchers want to make sure the sensor accurately measures blood sugar levels and is safe for people with diabetes. The study will compare it to an existing glucose monitoring system to confirm it works just as well.
Continuous glucose monitoring helps people with diabetes manage their blood sugar, but devices can always be improved. This study checks whether the new version of this sensor is as safe and accurate as the current version, which helps ensure patients get the best technology available.
You likely qualify if…
You likely don't qualify if…
You would have the new glucose sensor inserted under your skin (similar to how the current system works) and wear a small transmitter device on your arm. The study will compare how well this sensor measures your blood sugar against standard laboratory tests. You'll need to visit the study center multiple times to have your sensor checked, blood samples taken, and to have the sensor removed after the study period ends.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States